Actinver Wealth Management, Inc. Buys iShares 20+ Year Treasury Bond ETF, iShares Core MSCI EAFE ETF, iShares iBoxx $ Investment Grade Corporate Bond ET, Sells Apple Inc, Celgene Corp, Lam Research Corp

Investment company Actinver Wealth Management, Inc. (Current Portfolio) buys iShares 20+ Year Treasury Bond ETF, iShares Core MSCI EAFE ETF, iShares iBoxx $ Investment Grade Corporate Bond ET, iShares Core Dividend Growth ETF, ProShares UltraShort S&P500, sells Apple Inc, Celgene Corp, Lam Research Corp, Taro Pharmaceutical Industries, Goldman Sachs Group Inc during the 3-months ended 2019Q2, according to the most recent filings of the investment company, Actinver Wealth Management, Inc.. As of 2019Q2, Actinver Wealth Management, Inc. owns 83 stocks with a total value of $71 million. These are the details of the buys and sells.

For the details of Actinver Wealth Management, Inc.'s stock buys and sells, go to https://www.gurufocus.com/guru/actinver+wealth+management%2C+inc./current-portfolio/portfolio

These are the top 5 holdings of Actinver Wealth Management, Inc.
  1. iShares Edge MSCI Min Volatility USA ETF (USMV) - 120,639 shares, 10.54% of the total portfolio. Shares added by 3.57%
  2. iShares 1-3 Year Treasury Bond ETF (SHY) - 47,468 shares, 5.70% of the total portfolio. Shares added by 8.19%
  3. AT&T Inc (T) - 95,612 shares, 4.54% of the total portfolio. Shares reduced by 38.49%
  4. Apple Inc (AAPL) - 15,547 shares, 4.36% of the total portfolio. Shares reduced by 46.93%
  5. Technology Select Sector SPDR Fund (XLK) - 30,959 shares, 3.42% of the total portfolio. Shares reduced by 9.44%
New Purchase: iShares 20+ Year Treasury Bond ETF (TLT)

Actinver Wealth Management, Inc. initiated holding in iShares 20+ Year Treasury Bond ETF. The purchase prices were between $122.21 and $132.9, with an estimated average price of $126.95. The stock is now traded at around $144.04. The impact to a portfolio due to this purchase was 2.03%. The holding were 10,801 shares as of .

New Purchase: ProShares UltraShort S&P500 (SDS)

Actinver Wealth Management, Inc. initiated holding in ProShares UltraShort S&P500. The purchase prices were between $30.55 and $35.48, with an estimated average price of $32.19. The stock is now traded at around $30.80. The impact to a portfolio due to this purchase was 0.56%. The holding were 13,000 shares as of .

New Purchase: iShares MBS ETF (MBB)

Actinver Wealth Management, Inc. initiated holding in iShares MBS ETF. The purchase prices were between $105.63 and $107.66, with an estimated average price of $106.4. The stock is now traded at around $108.11. The impact to a portfolio due to this purchase was 0.51%. The holding were 3,319 shares as of .

New Purchase: International Business Machines Corp (IBM)

Actinver Wealth Management, Inc. initiated holding in International Business Machines Corp. The purchase prices were between $126.99 and $145.14, with an estimated average price of $137.38. The stock is now traded at around $135.04. The impact to a portfolio due to this purchase was 0.43%. The holding were 2,221 shares as of .

New Purchase: Merck & Co Inc (MRK)

Actinver Wealth Management, Inc. initiated holding in Merck & Co Inc. The purchase prices were between $73.19 and $85.51, with an estimated average price of $80.15. The stock is now traded at around $86.19. The impact to a portfolio due to this purchase was 0.4%. The holding were 3,359 shares as of .

New Purchase: iShares Core Moderate Allocation ETF (AOM)

Actinver Wealth Management, Inc. initiated holding in iShares Core Moderate Allocation ETF. The purchase prices were between $37.42 and $38.74, with an estimated average price of $37.93. The stock is now traded at around $38.83. The impact to a portfolio due to this purchase was 0.36%. The holding were 6,550 shares as of .

Added: iShares Core MSCI EAFE ETF (IEFA)

Actinver Wealth Management, Inc. added to a holding in iShares Core MSCI EAFE ETF by 232.90%. The purchase prices were between $58.22 and $61.5, with an estimated average price of $60.25. The stock is now traded at around $58.63. The impact to a portfolio due to this purchase was 1.38%. The holding were 22,647 shares as of .

Added: iShares iBoxx $ Investment Grade Corporate Bond ET (LQD)

Actinver Wealth Management, Inc. added to a holding in iShares iBoxx $ Investment Grade Corporate Bond ET by 60.39%. The purchase prices were between $118.17 and $124.37, with an estimated average price of $120.06. The stock is now traded at around $127.43. The impact to a portfolio due to this purchase was 1.26%. The holding were 18,961 shares as of .

Added: iShares Core Dividend Growth ETF (DGRO)

Actinver Wealth Management, Inc. added to a holding in iShares Core Dividend Growth ETF by 149.46%. The purchase prices were between $35.71 and $38.38, with an estimated average price of $37.29. The stock is now traded at around $37.96. The impact to a portfolio due to this purchase was 1.11%. The holding were 34,291 shares as of .

Added: iShares Core S&P 500 ETF (IVV)

Actinver Wealth Management, Inc. added to a holding in iShares Core S&P 500 ETF by 24.76%. The purchase prices were between $274.69 and $296.02, with an estimated average price of $288.3. The stock is now traded at around $294.07. The impact to a portfolio due to this purchase was 0.52%. The holding were 6,239 shares as of .

Added: PowerShares QQQ Trust Ser 1 (QQQ)

Actinver Wealth Management, Inc. added to a holding in PowerShares QQQ Trust Ser 1 by 23.21%. The purchase prices were between $170.12 and $191.11, with an estimated average price of $184. The stock is now traded at around $188.43. The impact to a portfolio due to this purchase was 0.31%. The holding were 6,249 shares as of .

Added: Citigroup Inc (C)

Actinver Wealth Management, Inc. added to a holding in Citigroup Inc by 52.76%. The purchase prices were between $62.15 and $71.03, with an estimated average price of $66.92. The stock is now traded at around $64.31. The impact to a portfolio due to this purchase was 0.2%. The holding were 5,820 shares as of .

Sold Out: Taro Pharmaceutical Industries Ltd (TARO)

Actinver Wealth Management, Inc. sold out a holding in Taro Pharmaceutical Industries Ltd. The sale prices were between $83.92 and $108.88, with an estimated average price of $98.91.

Sold Out: iShares MSCI Turkey ETF (TUR)

Actinver Wealth Management, Inc. sold out a holding in iShares MSCI Turkey ETF. The sale prices were between $20.24 and $25.66, with an estimated average price of $22.93.

Sold Out: MSCI United Kingdom Index Fund (EWU)

Actinver Wealth Management, Inc. sold out a holding in MSCI United Kingdom Index Fund. The sale prices were between $30.9 and $33.09, with an estimated average price of $32.22.

Sold Out: Alexion Pharmaceuticals Inc (ALXN)

Actinver Wealth Management, Inc. sold out a holding in Alexion Pharmaceuticals Inc. The sale prices were between $113.68 and $141.3, with an estimated average price of $128.81.

Sold Out: iShares MSCI China ETF (MCHI)

Actinver Wealth Management, Inc. sold out a holding in iShares MSCI China ETF. The sale prices were between $54.88 and $65.03, with an estimated average price of $60.06.

Sold Out: SPDR Barclays High Yield Bond ETF (JNK)

Actinver Wealth Management, Inc. sold out a holding in SPDR Barclays High Yield Bond ETF. The sale prices were between $105.16 and $108.96, with an estimated average price of $106.88.



Here is the complete portfolio of Actinver Wealth Management, Inc.. Also check out:

1. Actinver Wealth Management, Inc.'s Undervalued Stocks
2. Actinver Wealth Management, Inc.'s Top Growth Companies, and
3. Actinver Wealth Management, Inc.'s High Yield stocks
4. Stocks that Actinver Wealth Management, Inc. keeps buying